The global cannula market size was valued at USD 204.22 million in 2025 and is projected to grow from USD 219.43 million in 2026 to USD 389.90 million by 2034, registering a CAGR of 7.45% during the forecast period from 2026 to 2034. North America dominated the cannula market with a market share of 38.5% in 2025.
A cannula is a thin, hollow medical tube designed to provide access to blood vessels, body cavities, or tissues for the administration or removal of fluids, medications, gases, or biological materials. Cannulas are commonly used for intravenous therapy, oxygen delivery, blood collection, drainage, and surgical procedures. They are available in different sizes, shapes, and materials depending on their intended clinical application.
Download a Free Sample To learn more about this report,
Shift Toward Safety-Enhanced and Procedure-Specific Cannula Designs
The cannula market is shifting from standardized access devices toward safety-enhanced and procedure-specific designs that improve insertion control, reduce procedural complications, and address the requirements of increasingly specialized clinical applications. Manufacturers are focusing on features such as improved tip geometry, better stability, enhanced biocompatibility, needle-free access, and application-specific configurations for vascular, respiratory, cardiovascular, and surgical procedures. This evolution is increasing product differentiation and encouraging healthcare providers to prioritize cannulas that combine reliable clinical performance with greater procedural precision and patient safety.
Rising Volume of Hospital Procedures and Vascular Access Requirements
Demand for cannulas is increasing with the growing volume of hospital procedures that require reliable vascular access for medication administration, fluid delivery, blood sampling, anesthesia, and other clinical interventions. The continued use of intravenous and vascular access procedures across acute-care settings creates recurring demand for cannulas, while expanding surgical and emergency-care activity increases utilization across different patient populations. This broad clinical dependence on dependable access devices supports consistent replacement and consumption requirements across hospitals and other healthcare facilities.
Product Cost and Procurement Sensitivity
Market adoption can be constrained by the price sensitivity of healthcare providers and centralized procurement systems, particularly because many cannulas are high-volume consumable devices purchased under strict cost-control requirements. Hospitals and clinics may prioritize standardized products with established supplier relationships when clinical performance differences are perceived as limited, making it difficult for premium-priced products to gain rapid penetration. Competitive tendering, budget limitations, and pressure to control recurring medical-device expenditure can therefore restrict manufacturers' ability to translate advanced features into higher selling prices.
Expansion of Specialized Cannulas for Minimally Invasive and Advanced Procedures
Additional growth opportunities are emerging from the increasing use of minimally invasive and specialized procedures that require cannulas with specific dimensions, access characteristics, stability, and compatibility with advanced procedural systems. Applications spanning cardiovascular interventions, endoscopic procedures, aesthetic treatments, and robotic surgery can create demand for purpose-built cannula configurations rather than generic access products. Manufacturers that develop application-specific designs and establish compatibility with evolving procedural technologies can therefore expand into higher-value clinical niches and diversify beyond conventional vascular access applications.
Maintaining Sterility, Biocompatibility, and Consistent Clinical Performance
The market faces an industry-level challenge in maintaining stringent safety and quality requirements across increasingly diverse cannula designs and applications. Manufacturers must consistently control material quality, dimensional accuracy, sterility, packaging integrity, mechanical performance, and biocompatibility while meeting regulatory requirements for different clinical uses and geographic markets. Variations in manufacturing processes or material properties can affect insertion performance, flow characteristics, device integrity, or patient outcomes, making rigorous validation, quality assurance, and regulatory compliance essential throughout the product lifecycle.
Peripheral Cannula Segment is Projected to Register the Fastest Growth at a CAGR of 7.91%
The peripheral cannula segment is projected to register the fastest growth at a CAGR of 7.91% during 2026–2034. In 2025, the segment accounted for 31.8% of the global cannula market, with a value of USD 0.06 billion. Growth is driven by increasing use of peripheral cannulas for routine intravenous access, rising healthcare procedures, and growing demand for efficient and minimally invasive methods of fluid and medication administration. Expanding hospital and outpatient care continues to support the segment's growth.
The intravenous cannula segment dominated the market with a 54.6% share and a value of USD 0.11 billion, supported by its widespread use for intravenous fluid administration, medication delivery, and other clinical procedures. The nasal cannula segment accounted for 30.7% of the market, while the central line cannula segment represented 14.2%.
Draining cannulas accounted for 8.6% of the market, while other cannula products represented 14.7%. These products continue to support specialized clinical procedures across healthcare settings.
Request Customizationto receive a tailored report.
Oxygen Delivery Segment is Projected to Register the Fastest Growth at a CAGR of 7.86%
The oxygen delivery segment is projected to register the fastest growth at a CAGR of 7.86% during 2026–2034. In 2025, the segment accounted for 34.9% of the global cannula market, with a value of USD 0.07 billion. Growth is driven by increasing demand for respiratory support, rising prevalence of respiratory conditions, and growing use of cannulas for oxygen administration across hospitals, clinics, and other healthcare settings.
Anaesthesia and surgery accounted for 28.4% of the market, with a value of USD 0.06 billion. Administration of medicine represented 20.9% of the market, supported by the widespread use of cannulas for controlled medication delivery during healthcare procedures.
Blood sampling accounted for 15.8% of the market, with a value of USD 0.03 billion. Continued demand for efficient blood collection procedures supports the use of cannulas in relevant clinical applications.
22G Segment is Projected to Register the Fastest Growth at a CAGR of 7.96%
The 22G segment is projected to register the fastest growth at a CAGR of 7.96% during 2026–2034. In 2025, the segment accounted for 22.1% of the global cannula market, with a value of USD 0.05 billion. Growth is driven by increasing use of appropriate cannula sizes across clinical procedures, rising demand for patient-specific vascular access, and continued adoption in routine healthcare applications.
The 20G segment dominated the market with a 29.4% share and a value of USD 0.06 billion. The 18G segment accounted for 25.7% of the market, while the 14G segment represented 9.6%. These sizes continue to support different requirements for fluid administration and vascular access.
Plastic Segment is Projected to Register the Fastest Growth at a CAGR of 7.69%
The plastic segment is projected to register the fastest growth at a CAGR of 7.69% during 2026–2034. In 2025, the segment accounted for 62.8% of the global cannula market, with a value of USD 0.13 billion. Growth is driven by the widespread use of plastic cannulas, their suitability for disposable medical devices, and increasing demand for convenient and cost-effective cannula products across healthcare settings.
Stainless steel accounted for 24.6% of the market, with a value of USD 0.05 billion. Its continued use in specific medical applications is supported by its durability and established role in healthcare procedures.
Silicon represented 12.6% of the market, with a value of USD 0.03 billion. The material continues to support cannula applications where flexibility and material compatibility are important considerations.
Ambulatory Surgical Centres Segment is Projected to Register the Fastest Growth at a CAGR of 8.12%
The ambulatory surgical centres segment is projected to register the fastest growth at a CAGR of 8.12% during 2026–2034. In 2025, the segment accounted for 21.3% of the global cannula market, with a value of USD 0.04 billion. Growth is driven by the increasing shift toward outpatient procedures, expanding ambulatory surgical infrastructure, and rising demand for efficient medical devices during same-day surgical and procedural care.
Hospitals and clinics dominated the market with a 68.5% share and a value of USD 0.14 billion, supported by high procedure volumes, extensive patient care activities, and widespread use of cannulas for medication administration, fluid delivery, oxygen therapy, and other clinical procedures.
Other end users accounted for 10.2% of the market, with a value of USD 0.02 billion. This segment continues to contribute to demand through cannula applications across additional healthcare and clinical settings.
Speak to an Analystto discuss market opportunities.
North America cannula market accounted for 38.5% of the global market, reaching USD 0.08 billion in 2025, and is projected to grow at a CAGR of 7.05% during the forecast period. The market is driven by increasing surgical and minimally invasive procedures, rising demand for cosmetic and medical applications, growing healthcare expenditure, and expanding adoption of advanced cannula technologies. Increasing demand across hospitals, specialty clinics, and aesthetic centers continues to support regional market growth.
The US market is supported by increasing surgical and aesthetic procedures, growing demand for minimally invasive treatments, rising healthcare expenditure, and expanding adoption of advanced cannula products across hospitals and specialty clinics.
Canada's market growth is driven by increasing healthcare investments, growing surgical procedures, rising demand for minimally invasive medical devices, and expanding adoption of cannula products across healthcare facilities.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe cannula market accounted for 27.2% of the global market, reaching USD 0.06 billion in 2025, and is projected to grow at a CAGR of 6.82% during the forecast period. Increasing surgical procedures, growing demand for minimally invasive treatments, rising healthcare expenditure, and expanding aesthetic medicine applications continue to strengthen regional market growth. Increasing adoption of advanced medical devices and growing healthcare infrastructure further support market expansion.
The UK market is supported by increasing demand for minimally invasive procedures, growing aesthetic medicine activities, rising surgical volumes, and expanding adoption of advanced cannula technologies across healthcare and specialty clinics.
Germany market growth is driven by strong healthcare infrastructure, increasing surgical procedures, growing demand for advanced medical devices, and rising adoption of minimally invasive technologies in hospitals and specialty healthcare facilities.
Asia Pacific cannula market accounted for 22.8% of the global market, reaching USD 0.05 billion in 2025, and is projected to grow at a CAGR of 8.96% during the forecast period. Rapid healthcare infrastructure development, increasing surgical procedures, rising medical expenditure, and growing adoption of minimally invasive treatments continue to accelerate regional market growth. Expanding aesthetic medicine and increasing demand for advanced medical devices further strengthen market expansion.
China's market is supported by expanding healthcare infrastructure, increasing surgical and aesthetic procedures, growing investments in medical technologies, and rising demand for minimally invasive medical devices.
Japan's market growth is driven by an aging population, increasing demand for surgical care, growing adoption of minimally invasive procedures, and rising investments in advanced healthcare and medical device technologies.
Middle East and Africa cannula market accounted for 5.1% of the global market, totaling USD 0.01 billion in 2025, and is projected to grow at a CAGR of 6.74% during the forecast period. Increasing healthcare infrastructure investments, growing surgical procedures, expanding aesthetic medicine activities, and rising demand for minimally invasive medical devices continue to support regional market growth.
The UAE market is supported by increasing investments in advanced healthcare facilities, growing medical tourism, rising demand for aesthetic and minimally invasive procedures, and expanding adoption of advanced medical devices.
Africa's market growth is supported by expanding healthcare infrastructure, increasing access to surgical care, growing investments in medical facilities, and rising demand for minimally invasive medical devices, creating long-term opportunities for cannula adoption across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Cardiac Resynchronization Therapy (CRT) Market Size, Share, 2034
Automated External Defibrillators Market Size, Share, Growth, 2034
Assisted Walking Devices Market Size, Share, Growth, 2034
Artificial Organs Market Size, Share, Growth, Forecast, 2034
Airway Management Devices Market Size, Share, Growth, Analysis, 2034
Angiography Catheters Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com